MIRM FY 2023 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MIRMMirum Pharmaceuticals, Inc.

$5B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$186M+141.8% YoY

Gross Profit

$139M74.8% margin

Operating Income

-$109M-58.6% margin

Net Income

-$163M-87.7% margin

EPS (Diluted)

$-4.00

Cash Flow

Operating Cash Flow

-$71M

Free Cash Flow

-$91M

Stock-Based Comp.

$35M

Balance Sheet

Total Assets

$647M

Total Liabilities

$398M

Stockholders' Equity

$249M

Cash & Equivalents

$286M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$186M	$77M	+141.8%
Gross Profit	$139M	$65M	+115.4%
Operating Income	-$109M	-$131M	+16.8%
Net Income	-$163M	-$136M	-20.5%